Pier 88 Investment Partners LLC Denali Therapeutics Inc. Transaction History

Pier 88 Investment Partners LLC

$62.9 Million
Q1 2024

A detailed history of Pier 88 Investment Partners LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 39,970 shares of DNLI stock, worth $846,964. This represents 1.3% of its overall portfolio holdings.

Number of Shares

39,970

Previous 45,240 11.65%

Holding current value

$846,964

Previous $970,000 15.46%

% of portfolio

1.3%

Previous 1.5%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$15.83 - $23.35 $83,424 - $123,054	-5,270 Reduced 11.65%	39,970 $820,000
Q4 2023 Feb 09, 2024	SELL	$16.2 - $23.18 $88,452 - $126,562	-5,460 Reduced 10.77%	45,240 $970,000
Q3 2023 Nov 09, 2023	BUY	$20.63 - $30.17 $62,302 - $91,113	3,020 Added 6.33%	50,700 $1.05 Million
Q2 2023 Aug 07, 2023	BUY	$23.37 - $32.96 $113,110 - $159,526	4,840 Added 11.3%	47,680 $1.41 Million
Q1 2023 May 09, 2023	BUY	$21.91 - $32.67 $166,516 - $248,292	7,600 Added 21.57%	42,840 $987,000

Q4 2022 Feb 08, 2023	BUY	$26.28 - $33.92 $608,382 - $785,248	23,150 Added 191.48%	35,240 $980,000
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $25,710 - $38,144	-990 Reduced 7.57%	12,090 $371,000
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $272,901 - $459,933	13,070 Added 130700.0%	13,080 $385,000
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $959,030 - $1.56 Million	-33,070 Reduced 99.97%	10 $0
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $604,778 - $781,284	14,200 Added 75.21%	33,080 $1.48 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $230,764 - $372,374	4,760 Added 33.71%	18,880 $952,000
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $329,968 - $514,566	6,560 Added 86.77%	14,120 $1.11 Million
Q1 2021 May 14, 2021	SELL	$53.8 - $81.53 $283,257 - $429,255	-5,265 Reduced 41.05%	7,560 $432,000
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $847,363 - $2.15 Million	-22,970 Reduced 64.17%	12,825 $3.3 Million
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $381,968 - $641,403	-16,514 Reduced 31.57%	35,795 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $73,790 - $132,831	4,609 Added 9.66%	52,309 $1.27 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $80,940 - $159,486	5,700 Added 13.57%	47,700 $835,000
Q4 2019 Feb 14, 2020	BUY	$14.4 - $19.99 $20,016 - $27,786	1,390 Added 3.42%	42,000 $732,000
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $198,547 - $284,083	12,960 Added 46.87%	40,610 $622,000
Q2 2019 Aug 08, 2019	SELL	$18.5 - $28.14 $153,180 - $232,999	-8,280 Reduced 23.04%	27,650 $574,000
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $176,301 - $241,570	9,800 Added 37.5%	35,930 $834,000
Q4 2018 Feb 11, 2019	SELL	$13.88 - $21.75 $163,784 - $256,650	-11,800 Reduced 31.11%	26,130 $540,000
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $472,607 - $824,598	37,930 New	37,930 $825,000

Others Institutions Holding DNLI

# of Institutions

217

Shares Held

115M

Call Options Held

142K

Put Options Held

90.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.84B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Account

Pier 88 Investment Partners LLC Denali Therapeutics Inc. Transaction History